CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04561557
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:09.810114+00:00
Published At: 2024-10-30T00:00:00+00:00
Record Updated At: 2024-10-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-30"
protocolSection.identificationModule.nctId: "NCT04561557"
protocolSection.identificationModule.officialTitle: "An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.